Idenix Pharmaceuticals Inc – Indentures – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Indentures Filter

from S-3 7 pages Form of Subordinated Note

from S-3 7 pages Form of Senior Note

from S-3 60 pages Idenix Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities

from S-3 55 pages Idenix Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities

from SC 13D/A 1 page August 8, 2012 the Undersigned Hereby Certifies That Dr. Martin Henrich and Knut Mager Are Authorized to Execute Amendment No. 7 to Schedule 13d With Respect to Idenix Pharmaceuticals, Inc., on Behalf of Novartis AG. /S/ Peter Rupprecht Name: Peter Rupprecht Title: Senior Corporate Counsel

from S-3ASR 7 pages Form of Subordinated Note

from S-3ASR 7 pages Form of Senior Note

from S-3ASR 60 pages Idenix Pharmaceuticals, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities

from S-3ASR 55 pages Idenix Pharmaceuticals, Inc. and Trustee Indenture Dated as of Senior Debt Securities

from S-8 2 pages Certificate of Amendment of Restated Certificate of Incorporation of Idenix Pharmaceuticals, Inc

from S-1/A 1 page Specimen of Certificate